Please provide your email address to receive an email when new articles are posted on . The IC-OS definition of immune checkpoint inhibitor-associated myocarditis demonstrated good diagnostic ... Mounting data on mRNA vaccination against COVID-19 continued to suggest a small excess risk of myocarditis, especially in young men and adolescent boys.

Understanding the Context

Based on voluntary reports to the passive ... AMSTERDAM -- Anti-inflammatory immunosuppressant anakinra (Kineret) held no survival benefit for acute myocarditis, the randomized phase IIb ARAMIS trial showed. The interleukin-1 receptor antagonist ... AMSTERDAM — A short course of the interleukin-1 receptor antagonist, anakinra, appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.

Key Insights

The trial was presented at the ... Rates of myocarditis remain low following administration of a third dose of the COVID-19 vaccine from Pfizer/BioNTech, with the possibility of even lower rates than were seen after the initial ... TCTMD: As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise? Reports of myocarditis developing after receipt of one of the mRNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna are understandably concerning, though the complication appears rare and has ... As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

Final Thoughts